Skip to main content

Table 3 Characteristics of patients according to C3435T genotypes

From: Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma

Characteristics CC genotype
N (%)
CT genotype
N (%)
TT genotype
N (%)
P-value
Age at diagnosis     
< 30 (n = 62) 7 (46.7) 28 (45.2) 27 (50.9) 0.823
≥ 30 (n = 68) 8 (53.3) 34 (54.8) 26 (49.1)  
Gender     
Males (n = 71) 7 (46.7) 29 (46.8) 35 (66) 0.095
Females (n = 59) 8 (53.3) 33 (53.2) 18 (44)  
Histology     
NSa (n = 62) 9 (64.3) 32 (72.7) 21 (60) 0.481
MCb (n = 31) 5 (35.7) 12 (27.3) 14 (40)  
Stage     
Early stages (I &II) (n = 61) 7 (50) 30 (58) 24 (53.3) 0.842
Advanced stages (III & IV) (n = 50) 7 (50) 22 (42) 21 (46.7)  
Presence of B-symptoms     
Yes (n = 73) 9 (60) 36 (64.3) 28 (60.9) 0.920
No (n = 44) 6 (40) 20 (35.7) 18 (39.1)  
  1. aNodular sclerosis; bMixed cellularity.